Thrombin generation assay and transmission electron microscopy: A useful combination to study tissue factor-bearing microvesicles

Journal of Extracellular Vesicles

Volumn 2, Issue 1, 2013, Pages

  Gheldof, Damien ^a,b   Hardij, Julie ^a   Cecchet, Francesca ^a   Chatelain, Bernard ^b   Dogné, Jean Michel ^a   Mullier, François ^a,b  

^a University of Namur   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cancer; Microvesicles; Thrombin generation; Tissue factor

Indexed keywords

LIPOCORTIN 5; MUCIN 1; PHOSPHOLIPID; PROTEIN ANTIBODY; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CENTRIFUGATION; CONTROLLED STUDY; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE VESICLE; MICROVESICLE; MOLECULAR SIZE; PHOSPHOLIPID MEMBRANE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; SUPERNATANT; THROMBIN GENERATION ASSAY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 85013397596     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v2i0.19728     Document Type: Article

References (34)

1. Gerotziafas GT, Galea V, Mbemba E, Kartechi A, Sassi M, Baccouche H, et al. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7. Thromb Res. 2011;129:779-86.
2. Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res. 2010;125:511-2.
3. Noble S, Pasi J. Epidemiology and pathophysiology of cancerassociated thrombosis. Br J Cancer. 2010;102(Suppl 1):S2-9.
4. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111: 4902-7.
5. Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circulation Res. 2011;108:1284-97.
6. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009;15:6830-40.
7. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol. 2009;27:4834-8.
8. van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost. 2010;8:2596-607.
9. Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties. Thromb Res. 2010;125(Suppl 1):S46-S8.
10. Zwicker JI. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb Res. 2010;125(Suppl 2):S89-91.
11. Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost. 2008;6:1517-24.
12. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg. 2009;108:1447-52.
13. Dargaud Y, Negrier C. Thrombin generation testing in haemophilia comprehensive care centres. Haemophilia. 2010;16:223-30.
14. Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost. 2010;36:865-75.
15. Robert S, Ghiotto J, Pirotte B, David JL, Masereel B, Pochet L, et al. Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs? Pharmacol Res. 2009;59:160-6.
16. Serda RE, Godin B, Blanco E, Chiappini C, Ferrari M. Multistage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta. 2011;1810:317-29.
17. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007;5:520-7.
18. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32:249-53.
19. Wang JG, Manly D, Kirchhofer D, Pawlinski R, Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost. 2009;7:1092-8.
20. Gessler F, Voss V, Dutzmann S, Seifert V, Gerlach R, Kogel D. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience. 2010;165:1312-22.
21. Peng L, Jiang H, Bradley C. Annexin V for flow cytometric detection of phosphatidylserine expression on lymphoma cells undergoing apoptosis [in Chinese]. J West China Univ Med Sci. 2001;32:620-4, 620.
22. Conover WJ. Practical nonparametric statistics. 3rd edition. New York: John Wiley; 1999.
23. Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, et al. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol. 2009;27: 4919-26.
24. van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost. 2012;10: 919-30.
25. Brisson AR, Tan S, Arraud N, Gounou C. Plasmatic microvesicles: their size, morphology, phenotype revealed by cryo-electron microscopy and specific gold labeling. Int Soc Extracellular Vesicles. 2013.
26. Lacroix R, Robert S, Poncelet P, Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost. 2010;36:807-18.
27. Xiong G, Aras O, Shet A, Key NS, Arriaga EA. Analysis of individual platelet-derived microparticles, comparing flow cytometry and capillary electrophoresis with laser-induced fluorescence detection. Analyst. 2003;128:581-8.
28. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011;5: 7155-67.
29. Buzhynskyy N, Golczak M, Lai-Kee-Him J, Lambert O, Tessier B, Gounou C, et al. Annexin-A6 presents two modes of association with phospholipid membranes. A combined QCM-D, AFM and cryo-TEM study. J Struct Biol. 2009;168: 107-16.
30. Berny-Lang MA, Aslan JE, Tormoen GW, Patel IA, Bock PE, Gruber A, et al. Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells. Phys Biol. 2011;8:015014.
31. Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood. 2005;105:2764-70.
32. Butenas S, Parhami-Seren B, Mann KG. The influence of von Willebrand factor on factor VIII activity measurements. J Thromb Haemost. 2009;7:132-7.
33. Kocaturk B, Versteeg HH. Tissue factor isoforms in cancer and coagulation: may the best isoform win. Thromb Res. 2012;129(Suppl 1):S69-75.
34. Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost. 2010;8:315-23.